利科哈尔B的治疗潜力和作用机制:一个小小的回顾
Sibhghatulla Shaikh1,2, Eun Ju Lee1,2, Khurshid Ahmad1,2
1Department of Medical Biotechnology, Yeungnam University, Gyeongsan, Republic of Korea.
甘草根中的一种化合物Licochalcone B显示出显著的抗癌,肝脏保护和抗炎作用. 其多样化的分子标表明了新药开发的巨大潜力.
科学领域:
- 药理学 药理学是指药理学的学科.
- 自然产品 化学 化学
- 药物发现 药物发现 药物发现
背景情况:
- 利科哈尔科尼B (LicB) 是一种从*Glycyrrhiza uralensis*和*Glycyrrhiza glabra*中分离出来的.
- LicB表现出广泛的药理活动,包括抗癌,肝脏保护,抗炎和神经保护作用.
- 它的治疗潜力归因于与多个分子标和信号通路的相互作用.
研究的目的:
- 系统地审查和更新最近关于LicB.的药理作用的发现.
- 阐明LicB生物活动背后的机械路径.
- 为突出LicB作为药物发现的领先化合物的潜力.
主要方法:
- 在临床前和临床研究的文献综述Licochalcone B.临床研究.
- 通过LicB.调制的分子目标和信号通路的分析.
- 对LicB.的治疗应用和药物开发潜力的证据综合.
主要成果:
- LicB显示出显著的抗癌,肝保护,抗炎和神经保护性质.
- 关键的分子标包括PI3K/Akt/mTOR,p53,NF-κB,以及p38.
- 证实了酶介导的亡,MAPK炎症途径和Nrf2抗氧化途径的参与.
结论:
- 利科哈尔康B具有具有显著治疗潜力的多方面的药理性质.
- 了解其复杂的作用机制为其发展成为新型治疗剂提供了基础.
- 在各种疾病领域,LicB代表了未来药物发现工作的有希望的支架.
更多相关视频
13:18Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
Published on: March 3, 2023
11:13Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
Published on: June 9, 2023
相关概念视频
Direct-Acting Cholinergic Agonists: Therapeutic Uses
Principles of Drug Action
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
The direct-acting...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Indirect-Acting Cholinergic Agonists: Mechanism of Action
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Direct-Acting Cholinergic Agonists: Pharmacokinetics
